Is SBRA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SBRA. It does not provide personalized investment advice.

SBRA (Sabra Healthcare REIT, Inc.) Stock Analysis - Financials

Sabra Healthcare REIT, Inc. (SBRA) is a publicly traded Real Estate sector company. As of July 13, 2026, SBRA trades at $19.79 with a market cap of $4.95B and a P/E ratio of 31.13. SBRA moved +0.92% today. Year to date, SBRA is +3.32%; over the trailing twelve months it is +6.80%. Its 52-week range spans $15.60 to $21.28. Analyst consensus is neutral with an average price target of $21.19. Rallies surfaces SBRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SBRA's key financials?

SBRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SBRA recently traded at $19.79. Market cap is $4.95B. P/E ratio is 31.13. Revenue is $812.84M.

SBRA Key Metrics

Key financial metrics for SBRA
Metric	Value
Price	$19.79
Market Cap	$4.95B
P/E Ratio	31.13
EPS	$0.63
Dividend Yield	0.30%
52-Week High	$21.28
52-Week Low	$15.60
Volume	380.65K
Avg Volume	0
Revenue (TTM)	$812.84M
Net Income	$156.02M
Gross Margin	0.00%

SBRA Analyst Consensus

9 analysts cover SBRA: 0 strong buy, 2 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $21.19.

Common questions about SBRA

What are SBRA's key financials?: SBRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SBRA recently traded at $19.79. Market cap is $4.95B. P/E ratio is 31.13. Revenue is $812.84M.
Is SBRA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SBRA. It does not provide personalized investment advice.